HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

Plantibodies

Plantibodies

Plantibodies, also known as plant-derived antibodies, are an emerging class of biologics that are produced from plants. They are composed of recombinant protein fragments, which are generated from plant expression systems. Plantibodies have a number of advantages over traditional animal-sourced antibodies. They are cost-effective and easier to manufacture, as they do not require animal serum, and they are also less likely to cause adverse reactions in patients due to their low immunogenicity. Plantibodies are also highly stable and can be produced at high yields, making them an attractive alternative to traditional antibodies. Plantibodies have been studied for a variety of therapeutic and diagnostic applications, such as cancer immunotherapies, infectious disease diagnostics, and allergy treatments. In addition, they are also being developed for use in vaccines and crop protection, making them a versatile and promising tool for medical and agricultural research.

Committee Members
Speaker at Plant Biology and Biotechnology 2026 - P E Rajasekharan

P E Rajasekharan

ICAR-IIHR, India
Speaker at Plant Biology and Biotechnology 2026 - Valasia Iakovoglou

Valasia Iakovoglou

UNESCO chair Con-E-Ect, International Hellenic University, Greece
Speaker at Plant Biology and Biotechnology 2026 - Rameshkumar K B

Rameshkumar K B

Jawaharlal Nehru Tropical Botanic Garden and Research Institute, India
GPB 2026 Speakers
Speaker at Plant Biology and Biotechnology 2026 - Selina Sterup Moore
Selina Sterup Moore
Aarhus University, Denmark

Submit your abstract Today

Signup for updates

By submitting this form, you are consenting to receive emails and notifications from Magnus Group. You can revoke your consent to receive emails at any time by using the Safe Unsubscribe link, found at the bottom of every email

Watsapp